MarkusHSLeungT.Stroke in China. Int J Stroke2023; 18: 256–258.
2.
ChunMQinHTurnbullI, et al. Heterogeneity in the diagnosis and prognosis of ischemic stroke subtypes: 9-year follow-up of 22,000 cases in Chinese adults. Int J Stroke2023; 18: 847–855.
3.
ZhaoYHuaXRenX, et al. Increasing burden of stroke in China: a systematic review and meta-analysis of prevalence, incidence, mortality, and case fatality. Int J Stroke2022; 18: 259–267.
4.
LiJChenQWangC, et al. The quality disparity of stroke care over time: an analysis based on the national dataset from 2011 to 2017. Int J Stroke2022; 18: 304–311.
5.
GuHQWangCJZhangXM, et al. Ten-year trends in sex differences in cardiovascular risk factors, in-hospital management, and outcomes of ischemic stroke in China: analyses of a nationwide serial cross-sectional survey from 2005 to 2015. Int J Stroke2023; 18: 821–828.
6.
XuJXieYFangK, et al. Effect of the Shanghai Stroke Service System (4S) on the quality of stroke care and outcomes: a prospective quality improvement project. Int J Stroke2023; 18: 599–606.
7.
LamBYKCaiYAkinyemiR, et al. The global burden of cerebral small vessel disease in low- and middle-income countries: a systematic review and meta-analysis. Int J Stroke2023; 18: 15–27.
8.
AlrohimiARoseDZBurginWS, et al. Risk of hemorrhagic transformation with early use of direct oral anticoagulants after acute ischemic stroke: a pooled analysis of prospective studies and randomized trials. Int J Stroke2023; 18: 864–872.
9.
FischerUKogaMStrbianD, et al. Early versus later anticoagulation for stroke with atrial fibrillation. N Engl J Med2023; 388: 2411–2421.
10.
KingBTLawrencePDMillingTJWarachSJ.Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START): methodology of a pragmatic, response-adaptive, prospective randomized clinical trial. Int J Stroke2019; 14: 977–982.
11.
BestJGArramLAhmedN, et al. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a randomized controlled trial. Int J Stroke2022; 17: 583–589.
12.
KimTJLeeJSYoonJS, et al. Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosis. Int J Stroke2023; 18: 812–820.
13.
Mota TellesJPRochaRBCenciGINagerGBSilvaGDFigueiredoEG.Prophylactic antiseizure drugs for spontaneous intracerebral hemorrhage: an updated systematic review and meta-analysis. Int J Stroke2022; 18: 773–782.
14.
GreenbergSMZiaiWCCordonnierC, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke2022; 53: e282–e361.
15.
FeiginVLBraininMNorrvingB, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke2022; 17: 18–29.
16.
GaoLLimMNguyenD, et al. The incidence of pediatric ischemic stroke: a systematic review and meta-analysis. Int J Stroke2023; 18: 765–772.
